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Abstract
The last decade has seen an explosion in models that describe phenomena in systems medicine. Such
models are especially useful for studying signaling pathways, such as the Wnt pathway. In this chapter
we use the Wnt pathway to showcase current mathematical and statistical techniques that enable mod-
elers to gain insight into (models of) gene regulation, and generate testable predictions. We introduce
a range of modeling frameworks, but focus on ordinary differential equation (ODE) models since they
remain the most widely used approach in systems biology and medicine and continue to offer great
potential. We present methods for the analysis of a single model, comprising applications of standard
dynamical systems approaches such as nondimensionalization, steady state, asymptotic and sensitivity
analysis, and more recent statistical and algebraic approaches to compare models with data. We present
parameter estimation and model comparison techniques, focusing on Bayesian analysis and coplanarity
via algebraic geometry. Our intention is that this (non exhaustive) review may serve as a useful starting
point for the analysis of models in systems medicine.
Keywords: Wnt signaling, model development, nondimensionalization, asymptotic analysis, parameter
inference, algebraic methods, model selection.
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1 Introduction
Despite the growing number of therapeutic options available to clinicians, gaps remain in our fundamen-
tal understanding of many biological processes. Acquiring this additional knowledge requires that we
focus on the molecular players that operate in intercellular and intracellular environments. Revealing the
complex networks and dynamics that control cellular, tissue- and host-level behavior, may enable us to
improve existing treatments and design new drug targets.
Many intercellular signals are initiated by signaling proteins such as cytokines and hormones. When
cytokines bind to receptors of a target cell, they trigger a cellular response by signal transduction path-
ways: multistep sequences of intracellular signaling events and communication between molecules.
Most of these molecules are proteins. Enzymes such as kinases and phosphatases, for example, cat-
alyze (respectively) the addition/removal of a phosphate group to/from a substrate, and thus perform a
crucial role in relaying information [1]. Phosphorylation (the addition of a phosphate group) can be as-
sociated with protein activation, and information can be communicated downstream, engaging multiple
signaling cascades by successive chemical reactions. While some reactions are linear, with the output
proportional to the input [2], many are complex, involving feedback loops or pathway redundancies.
3Often the output of these pathways is activation or inhibition of regulatory proteins called transcription
factors, which modify gene transcription and the cellular state.
To turn a gene on, an activated transcription factor translocates from the cytoplasm into the nucleus,
binds to the enhancer or promoter region of DNA, and RNA polymerase transcribes the DNA template
to synthesize RNA. Then messenger RNA (mRNA) leaves the nucleus and enters the cytoplasm where
ribosomes translate mRNA into protein [1]. Conversely, transcription factors may turn a gene off by
repressing the recruitment of RNA polymerase. These possible responses thus regulate protein synthesis.
In addition to subcellular processes that changes in protein synthesis stimulate, proteins may be released
by the cell and act as signaling molecules in other pathways.
Gene regulatory pathways are crucial to the normal functioning of cells, with many diseases caused
by dysfunction of one or more pathways. For example, signaling pathways such as NF-κB, MAP Kinase,
and Wnt/β -catenin are involved in a host of cellular processes and functions, including cancer. Due to
their complexity, a systems approach is needed to understand normal and aberrant pathway function.
Only by building theoretical models that describe how cells signal and validating/updating them using
experimental data can we develop new drug therapies that target specific diseases.
The remainder of the chapter is organized as follows. In Section 2, we review methods used to model
signal transduction pathways, and introduce an exemplary enzyme kinetics model. We then describe
the biology of Wnt signaling, with reference to relevant models, and introduce two models of the Wnt
signaling pathway that we focus on throughout the chapter to demonstrate various techniques. In Section
3, we detail methods that can be used to analyze a particular model and discuss the insight that each
approach can generate. In Section 4, we introduce techniques that can be used to compare models,
including some new methods for systems medicine. We conclude in Section 5 with a discussion of the
different techniques, and ideas for their further application in systems medicine.
2 Mathematical Modeling
Signaling pathways are complex and may be difficult to understand by linear logic alone. Theoretical
models can be used to gain insight into the dynamics of multiple biochemical interactions. Constructing a
mathematical model is a nontrivial task, that requires sufficient understanding of the system to determine
not only the type of model that should be used to address a particular question but also the limitations of
the model. After reviewing some of the modeling approaches that are used to study signaling pathways,
we focus on ordinary differential equation (ODE) models. We introduce basic principles that can be used
to construct ODE models and illustrate them by reference to enzyme kinetics and two models of the Wnt
pathway.
42.1 Modeling Approaches for Systems Medicine
Many processes associated with systems medicine in general, and signaling pathways in particular, can
be modeled. These include: gene/protein abundances; gene/protein interactions; abundances of cellular
species; the effects of cytokines, chemicals, drugs or other interventions on system or tissue-level phe-
nomena. Modeling strategies for systems medicine can be classified as either deterministic or stochastic;
we describe stochastic approaches briefly here, since the methods introduced in later sections are gener-
ally only applicable to deterministic systems.
Deterministic approaches describe systems for which, given full details of the model (parameter
values and initial conditions), its time evolution can be determined exactly. This means that if a system is
restarted multiple times from the same initial state it will always return to the same future states. Ordinary
and partial differential equations (PDEs) are two examples [3]. PDEs with two or more independent
variables (e.g., space and time) are more flexible than ODEs, but their simulation and analysis can be
computationally expensive. Deterministic methods provide accurate descriptions of population-level
behavior if the population sizes are large enough that the effects of random fluctuations can be neglected.
Stochastic approaches describe systems whose temporal evolution has unpredictable elements due
to randomness somewhere in the system. They are popular for modeling biological systems where ran-
domness and heterogeneity abound, and should be used when population sizes are small enough that
fluctuations cannot be ignored. In most cases, population averages will be recovered from a stochastic
model when the abundances become large enough. One can construct stochastic models of protein dy-
namics with stochastic differential equations [4] (i.e., ODEs with noise terms – often Gaussian – added).
Such models can be used to study the dynamics of species that fluctuate about a well-defined mean value.
Stochastic modeling can also be developed via agent-based approaches [5,6]. Here, individual agents
act according to a set of rules. For example, within a given pathway, a protein could be phosphorylated
or dephosphorylated with probabilities that depend on its environment. Such a framework treats protein
species very differently to differential equation methods: each protein is viewed as an autonomous agent
and population dynamics emerge in a “bottom up” manner. Whilst such methods may appeal to our
intuition about protein heterogeneity, the approach is limited since analyses are often computationally
expensive. As such, agent-based models should be used when population-averaged models fail to capture
the behavior that the modeler seeks to describe.
Cellular automata are a subset of agent-based models that impose spatial structure on the system by
constraining the agents to lie on a grid, in two or three dimensions [7, 8]. The agents are updated via
rules which may be deterministic or stochastic. Each grid point may be occupied by a finite number
of cells (typically only one) and the model can accommodate multiple cell types. Cellular automata
can account for spatial relationships between different cell types and have the advantage of being easy
to interpret biologically. A challenge associated with these models is that the update rules may not
translate clearly into biological hypotheses. Additionally, as for other agent-based models, simulation of
5cellular automata can be computationally expensive. Fitting such models to data is at the limits of what is
currently feasible since, despite significant advances in cellular imaging technology, obtaining cell data
of sufficient resolution and quality to fit to a model is rare.
The above overview of modeling approaches is not exhaustive: in limited space, we make no mention
of Boolean, semi-quantitative, hybrid, or branching processes. Instead, we continue by explaining how
to develop ODE models for signaling pathways.
2.2 Formulating Mathematical Models of Signaling Pathways
In this section our focus is on using ODEs to develop dynamic models of signaling pathways. Two basic
principles are integral to the development of such models:
• The Principle of Mass Balance states that the rate of change of a species is equal to the difference
between the rate at which the species is added to the system and the rate at which it is removed;
• The Law of Mass Action states that a reaction proceeds at a rate proportional to the product of its
reactants.
If, for example, substrate A is irreversibly phosphorylated by enzyme B, to produce C then we write
A+B r1−→C+B, (2.1)
where r1 is the rate at which phosphorylation occurs. We construct ODEs that describe the dynamics of
A, B and C by appealing to the Principle of Mass Balance and the Law of Mass Action:
dA
dt
=−r1AB, dBdt =−r1AB+ r1AB≡ 0,
dC
dt
= r1AB. (2.2)
By inspecting the above ODEs, it is straightforward to deduce that the following quantities are preserved:
A+C = A0+C0, and B= B0,
where A(t = 0) = A0, B(t = 0) = B0 and C(t = 0) = C0 are prescribed as initial conditions. We can
exploit these Conservation Laws to simplify the governing equations: in this case, we can eliminate both
B and C and our model reduces to give
dA
dt
=−r1B0A, with A(t = 0) = A0 ⇒ A(t) = A0e−r1B0t .
Thus, substrate levels decay exponentially, at rate r1B0.
6Case Study I: The Enzyme Kinetics Model.
We now consider a biochemical reaction that is catalyzed by an enzyme. In more detail, the enzyme
E binds reversibly with the substrate S to form a complex C. While complexed with the substrate, the
enzyme converts it into a product P and the enzyme is recovered. We represent these reactions as follows:
E+S
k1

k−1
C k2→E+P.
By applying the Law of Mass Action to this reaction scheme and appealing to the Principle of Mass
Balance, we deduce that the following system of ODES describe the time-evolution of S, E, C and P:
dS
dt
=−k1ES+ k−1C, (2.3)
dE
dt
=−k1ES+(k−1+ k2)C, (2.4)
dC
dt
= k1ES− (k−1+ k2)C, (2.5)
dP
dt
= k2C. (2.6)
If we assume further that S(t = 0) = S0, E(t = 0) = E0,C(t = 0) = 0 and P(t = 0) = 0, and take suitable
combinations of the governing ODEs then we deduce
d
dt
(E+C) = 0 and
d
dt
(S+C+P) = 0, ⇒ E+C = E0 and S+C+P= S0,
We can exploit these conservation laws to eliminate E and P and obtain the following reduced model:
dS
dt
=−k1S(E0−C)+ k−1C, (2.7)
dC
dt
= k1S(E0−C)− (k−1+ k2)C, (2.8)
with S(t = 0) = S0 and C(t = 0) = 0. (2.9)
2.3 Modeling Wnt Signaling
Wnt signaling is implicated in many biological processes. The pathway is activated when Wnt ligands
bind to specific receptors on the cell surface, resulting in the stabilization and nuclear accumulation of the
transcriptional co-activator β -catenin. Canonical Wnt signaling encompasses cellular responses to exter-
nal Wnt stimuli mediated by β -catenin. Non-canonical describes cellular signaling and responses to Wnt
not mediated by β -catenin. The canonical Wnt pathway plays a key role in essential cellular processes
ranging from proliferation and cell specification during development to adult stem cell maintenance and
7A+N
Ca +G ANG
Dan
Yi Ya
Yin Yan
CXT
;
A⇤N⇤G
T
T
X Xp Xc
Xn Xpn
CXH
H Y ap/Taz
Y ap/Taz
CY T
P
Pn
;
DiDa
Da
Cytoplasm
Nucleus
Membrane
Figure 1. Reaction scheme that incorporates many different Wnt signaling models and additional
molecular players (e.g., Yap/Taz). Solid arrows denote direct reactions; long-dashed arrows denote
species that act as catalysts in degradation reactions; and dotted arrows denote alternative paths for the
direct activation of Y . Note that active/inactive forms of Y are equivalent to active/inactive forms of
ANG.
wound repair [9]. Dysfunction of Wnt signaling is implicated in many pathological conditions, including
degenerative diseases and cancer [10–12]. Despite further molecular advances [13–15], certain details
of the dynamics of the pathway are still not well understood.
The basic steps that constitute canonical Wnt signaling are as follows (although these are not undis-
puted; discussed below): Wnt binds to cell-surface receptors Frizzled and LRP5/6 [11] that transduce a
signal via a multi-step process involving Dishevelled (Dsh) to the so-called destruction complex (DC).
The DC contains forms of Axin, adenomatous polyposis coli (APC), glycogen synthase kinase 3 (GSK-
3), and casein kinase 1α (CK1α). In the absence of a Wnt signal, the DC actively degrades β -catenin
– which is being continually synthesized in the cell – by binding and phosphorylating the protein and
thus marking it for proteasomal degradation. Following Wnt stimulation, degradation of β -catenin is
inhibited through phosphorylation of DC member proteins. This leads to accumulation in the cytoplasm
8of free β -catenin, which is able to translocate to the nucleus where it can form a complex with T-cell
factor (TCF) and lymphoid-enhancing factor (LEF) proteins and, thereby, influence the transcription of
target genes associated with processes such as self-renewal and proliferation [16, 17].
In addition to these core mechanisms, evidence for other important processes has been found, some
of which may challenge the Wnt signaling paradigm. Spatial localization within the cell has been found
to be important not only for β -catenin but also for Dsh and DC member proteins including Axin, APC,
and GSK-3 [18–23]. There is also evidence of competitive binding of β -catenin to cell membrane pro-
teins such as E-cadherin [24] and intricate cross-talk with the Hippo pathway, this being mediated by
Yap and Taz which promote translocation of cytoplasmic β -catenin to the nucleus via phosphorylation
and then compete with TCF for β -catenin in the nucleus [25] . This spatial organization of Wnt pathway
members may be key to understanding the pathway, as some modeling suggests [26, 27]. Equally, an
alternative description for the degradation of β -catenin exists: in this picture, β -catenin can be actively
degraded while still bound to the DC, rather than being released marked for degradation [28]. Discrim-
inating between competing hypotheses is needed in order to fully elucidate canonical Wnt signaling:
mathematical modeling is a natural framework within which to achieve this.
The first quantitative model of Wnt/β -catenin signaling was developed in 2003 [29], based on data
from Xenopus extracts. Formulated as a system of ODEs, the model describes known interactions be-
tween core components of the canonical pathway, these being Wnt, Dishevelled, GSK3β , APC, Axin,
β -catenin and TCF. The DC is assumed to act only in the well-mixed cytoplasm and, hence, only cy-
toplasmic levels of pathway components are considered. Since its publication, the Lee model has been
extended in many ways (for recent reviews of mathematical models of Wnt signaling, see [16, 30]). The
effect of mutations in APC was investigated by Cho et al. [31], the action of Wnt inhibitors was studied
by Kogan et al. [32], and the impact of Wnt-ERK cross-talk considered by Kim et al. [33]. The effect
of competition for β -catenin with adhesion proteins was investigated by van Leeuwen et al. [34] while
Schmitz showed how shuttling of core proteins between cytoplasm and nucleus could influence pathway
dynamics [35, 36]. More recently, a new shuttling model was constructed that accounts not only for ex-
change of pathway proteins between the nucleus and cytoplasm, but also degradation of β -catenin while
it is bound to active destruction complex (DC) and activation of the DC by dephosphorylation of its
components [27]. Table 1 summarizes the key features of some of these models and Figure 1 illustrates
the localization and known interactions between key proteins involved in Wnt signaling.
We now present the Lee model [29] and the Schmitz model [36], using the notation presented in Table
2. These models, together with the enzyme kinetics model presented above, will be revisited throughout
the chapter to illustrate how the techniques introduced in sections 3 and 4 are applied to specific models.
9Biological Feature Lee van Leeuwen Schmitz Shuttle
β -catenin production X X X X
β -catenin degradation
(independent of DC)
X X × X
β -catenin degradation (dependent
on DC)
X X X X
β -catenin sequestration by DC X X X X
β -catenin sequestration by APC × × × ×
Shuttling of species between
cytoplasmic and nuclear
compartments
× × X X
Activation/inactivation of DC X X X X
Interaction with adhesion
molecules
× X × ×
Two β -catenin forms: transcription
only and transcription or adhesion
× X × ×
DC is represented by its constituent
parts
X × × ×
β -catenin binds individual parts
APC and Axin as well as DC
X × × ×
β -catenin binds to TCF to promote
transcription of target genes
X X X X
Table 1. Comparison of features across different models of Wnt signaling. For further details
see [27, 29, 34, 36].
Case Study II: The Lee Model
In its original form, the Lee model comprises 15 time-dependent ODEs for protein species and complexes
that participate in the Canonical Wnt pathway, the reaction rates being based on mass action kinetics [29].
The model targets the assembly of the destruction complex from the constituent parts of APC, Axin and
GSK3β . It does not distinguish between nuclear and cytoplasmic compartments, instead assuming that
all species are uniformly distributed throughout the cell. A schematic diagram of the reactions described
in the Lee model is given in Figure 2. Using the variable names defined in Table 2 and primes to denote
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Symbol Species Forms
X β -catenin Xp – marked for proteasomal degradation
Y Destruction complex Ya – active
(APC/Axin/GSK3β ) Yi – inactive
D Dishevelled Da – active
Di – inactive
A APC
N Axin
G GSK3β
T TCF
C Complex CXY – complex of X and Y (etc.)
Table 2. Definition of notation for the variables used by the Lee and Schmitz models.
differentiation with respect to time, the ODEs that specify this model are:
Di′ =−α1Di+α2Da, (2.10)
Da′ = α1Di−α2Da, (2.11)
Ya′ = α3Yi−α4Ya−α10XYa+α11CXY +α13CXY p, (2.12)
Yi′ = α6GCNA−α5DaYi−α3Yi+α4Ya−α7Yi, (2.13)
G′ = α5DaYi−α6GCNA+α7Yi, (2.14)
CNA′ = α5DaYi−α6GCNA+α7Yi+α8NA−α9CNA, (2.15)
A′ =−α8NA+α9CNA−α21XA+α22CXA, (2.16)
CXY ′ = α10XYa−α11CXY −α12CXY , (2.17)
CXY p′ = α12CXY −α13CXY p, (2.18)
Xp′ = α13CXY p−α14Xp, (2.19)
X ′ =−α10XYa+α11CXY +α15−α16X−α19XT +α20CXT −α21XA+α22CXA, (2.20)
N′ =−α8NA+α9CNA+α17−α18N, (2.21)
T ′ =−α19XT +α20CXT , (2.22)
CXT ′ = α19XT −α20CXT , (2.23)
CXA′ = α21XA−α22CXA. (2.24)
To facilitate comparison with the Schmitz model (see below), the non-negative rate constants αk, k ∈
(1,2, ...,22) have been redefined from those used in [29]. Wnt dependence is incorporated via the pa-
rameter α1 = α1(W ) that controls the activation of Dsh.
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Inspection of Eqs. (2.10)-(2.24) reveals that there are four conservations laws:
D0 = Di+Da,
G0 = G+Yi+Ya+CXY +CXY p,
A0 = A+Yi+Ya+CXY +CXY p+CXA+CNA,
T0 = T +CXT ,
the constants D0,G0,A0 and T0 denoting the (assumed constant) levels of Dishevelled, GSK3β , APC
and TCF initially present in the system. These conservation laws are consistent with experimental ob-
servations which suggest that levels of these proteins do not fluctuate during Wnt signaling (i.e. they are
produced and degraded at the same rates). They can be used to eliminate 4 variables and, in so doing, to
reduce the model from 15 to 11 ODEs. Further simplifications are achieved by assuming that all binding
processes, except those for the binding of GSK3β to APC/Axin, reach equilibrium rapidly and that all
species involving axin are present at low levels. Under these assumptions, and after some algebra, the
following expressions for D0,G,A,T,Xp,CXT ,CXY p and CNA are obtained:
Di = D0−Da, G= G0, A= A01+ α21α22X
, T =
T0
1+ α19α20X
, Xp =
α12
α14
CXY ,
CXT =
X .T0
1+ α19α20X
, CXA =
A0X
1+ α21α22X
, CXY p =
α12
α13
CXY , CNA =
α8
α9
A0N
1+ α21α22
,
and a reduced system of 7 ODEs for the remaining species is eventually recovered (equations not pre-
sented since they are rather involved and less instructive than Eqs. (2.10)-(2.24)). In [29], and [37] this
model reduction is performed in an ad-hoc manner; it would be instructive to repeat it by first nondimen-
sionalizing the governing equations (see section 3.2) and using asymptotic analysis to perform the model
reduction (see section 3.3).
Case Study III: The Schmitz Model
Like the Lee model, the Schmitz model [36] focuses on the canonical Wnt pathway. Key differences
between the Lee and Schmitz models are that the latter distinguishes between the cytoplasm and nucleus
and accounts for exchange of β -catenin and DC between these compartments (see Table 2 and Figure 3
for further description). In each compartment, DC binding to β -catenin leads to its phosphorylation, and
phosphorylated β -catenin is degraded. We use subscript n to denote species residing in the nucleus with
the exception of TCF (T ) and the β -catenin-TCF complex (CXT ); since these species are localized in the
nucleus and to facilitate comparison with the Lee model, the subscript is omitted. Using notation that is
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Figure 2. Schematic of the Lee model [29], which describes the activation of the destruction complex
and its effect on β -catenin in a single cellular compartment (cytoplasm and nucleus combined).
Notation of the model species is given in Table 2. Solid arrows represent reactions and dashed arrows
represent catalytic processes.
modified from that used in [36], the ODEs that define the Schmitz model are:
X ′ = δ0+(δ2Xn−δ1X)+(δ6CXY −δ5XYa), (2.25)
X ′n = (δ1X−δ2Xn)+(δ9CXYn−δ8XnYan)+(δ12CXT −δ11XnT ), (2.26)
X ′p = δ7CXY −δ13Xp, (2.27)
X ′pn = δ10CXYn−δ14Xpn, (2.28)
Y ′a = (δ4Yan−δ3Ya)+(δ6CXY −δ5XYa)+δ7CXY +(δ16Yi−δ15Ya), (2.29)
Y ′i = δ15Ya−δ16Yi, (2.30)
Y ′an = (δ3Ya−δ4Yan)+(δ9CXYn−δ8XnYan)+δ10CXYn, (2.31)
C′XY = (δ5XYa−δ6CXY )+δ7CXY , (2.32)
C′XYn = (δ8XnYan−δ9CXYn)−δ10CXYn, (2.33)
T ′ = δ12CXT −δ11XnT, (2.34)
C′XT = δ11XnT −δ12CXT , (2.35)
where δk (k= 1,2, . . . ,17) are non-negative rate constants and δ15 = δ15(W ) so that Wnt acts to inactivate
the destruction complex in the cytoplasm.
13
CXY
YaX;
Xp
Yi
;
YanXnT
CXT
CXY n
Xp ;
Cytoplasm
Nucleus
Figure 3. Schematic of the Schmitz model [36], which describes the interaction between β -catenin and
the destruction complex in two cellular compartments: cytoplasm and nucleus. Notation of the model
species is given in Table 2.
By taking appropriate combinations of Eqs. (2.25)-(2.35), it is straightforward to show that there are
two conservation laws:
Yi+Ya+Yan+CXY +CXYn = YTOT and T +CXT = T0, (2.36)
the constants Y0 and T0 denoting, respectively, the total number of molecules of DC and TCF in the
system, as determined from the initial conditions. These identities may be used to reduce the order of
the Schmitz model from 11 to 9. As explained below, further systematic simplifications may be possible
following model nondimensionalization and parameter estimation.
3 Techniques for the Analysis of a Specific Model
Once model construction is complete, the modeler aims to extract from it new insight. This can be done
in a number of ways: if no data are available, standard mathematical techniques can be used to increase
understanding of the behavior of the model; however if data are available, then it may be possible to
estimate model parameters. In this section we describe a number of techniques, some standard and
others less so, that can be used to analyze models. We demonstrate these methods by reference to the
models of enzyme kinetics and Wnt signaling introduced in Section 2.
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3.1 Steady State Analysis
Broadly speaking, the behavior of an ODE model can be categorized as either transient or steady state.
The latter describes the behavior at large timescales (t → ∞). For systems that reach single valued (i.e.
not oscillating) steady states, we refer to the long time values that system variables take as the fixed
points. Much theory exists for the analysis of fixed points, which can be helpful in characterizing model
behavior and predicting the effects of perturbations [38]. We continue by calculating the steady states for
the enzyme kinetics model and the Schmitz model (similar analysis can be performed for the Lee model
but the resulting expressions are rather involved and therefore omitted).
Case Study I: The Enzyme Kinetics Model (Steady State)
Setting ddt = 0 in Eqs. (2.3)–(2.6), we deduce that our model for enzyme kinetics evolves to the following
unique, steady state solution:
S= 0, E = E0, C = 0 and P= S0.
Thus, as expected, the reaction proceeds until all of the substrate S has been converted to product P.
Case Study III: The Schmitz Model (Steady State)
Setting ddt = 0 in equations (2.25)–(2.35) and manipulating the resulting algebraic equations supplies the
following expressions for Yan,Yi,Xp,Xpn,CXY ,CXYn,T and CXT in terms of X ,Xn and Ya:
Yan =
δ3
δ4
Ya, Yi =
δ15
δ16
Ya, Xp =
δ7
δ13
δ5
δ6+δ7
XYa, Xpn =
δ8
δ14
δ10
δ9+δ10
XYa,
CXY =
δ5
δ6+δ7
XYa, CXYn =
δ3
δ4
δ8
δ9+δ10
XnYa,
T =
(
1+
δ11
δ12
Xn
)−1
TTOT , CXT =
δ11
δ12
(
1+
δ11
δ12
Xn
)−1
XnTTOT ,
wherein Ya = Ya(X ,Xn) satisfies
YTOT = Ya
(
1+
δ3
δ4
+
δ15
δ16
+
δ5
δ6+δ7
X+
δ3
δ4
δ8
δ9+δ10
Xn
)
,
while Xn depends linearly on X via(
1+
δ3
δ4
+
δ15
δ16
)
=
δ5
δ6+δ7
(
δ7
δ0
YTOT −1
)
X+
δ8
δ9+δ10
δ3
δ4
(
δ10
δ0
YTOT −1
)
Xn, (3.1)
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and X solves a quadratic of the form
0 =A X2+BX+C (3.2)
where the constant coefficients A ,B and C are functions of the model parameters. For physically
realistic solutions, we require X ,Xn > 0. Therefore, we conclude that this model has at most two steady
states and at most one of them may be stable.
As models increase in complexity, the algebra usually prohibits the construction of analytical expres-
sions for the steady-state solutions. In the following sections we present other methods that can be used
to generate insight in such situations.
3.2 Nondimensionalization
When a mathematical model is first developed, the independent and dependent variables typically repre-
sent physical quantities (e.g., protein levels) which are measured in dimensional units (e.g., protein levels
may be measured as the number of molecules per unit volume or the number of molecules per cell). The
model may also contain parameters which relate to physical processes (e.g., reaction rates, Michaelis-
Menten constants) and are also dimensional (e.g., rates may be measured per second, per hour or per
day). Nondimensionalization involves recasting the model in terms of dimensionless (or unit-less) vari-
ables. This process is instructive for several reasons. First, the number of model parameters is typically
reduced. Second, the resulting dimensionless parameter groupings can provide useful information about
the system’s behavior. Further, if estimates of these parameters can be obtained and then compared, it
is possible to identify physical processes that dominate on a particular timescale and, thereby, rationale
to simplify the governing equations. We illustrate these concepts by nondimensionalizing the enzyme
kinetics and Schmitz models.
Case Study I: The Enzyme Kinetics Model (Nondimensionalization)
We introduce the dimensionless variables τ,s,e,c and p where
t = Tτ, S= S0s, E = E0e, C = E0c, P= S0p.
and the timescale T is specified below. It is natural to scale the complex C with E0 since the amount of
complex that forms is limited by the amount of enzyme present. If the enzyme is working effectively (i.e.,
serving as an efficient catalyst), then the amount of product created will be comparable to the amount of
substrate. Ttherefore, we scale P with S0 rather than E0.
There are several possible choices for the timescale T . Consider Eq. (2.3). Initially, when C = 0, the
maximum rate of uptake of S is k1E0 and similarly the initial rate of uptake of E is k1S0. The associated
timescales are T1 = 1/(k1E0) and T2 = 1/(k1S0). Since enzyme levels are typically much smaller than
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substrate levels (i.e., E0/S0 = ε 1), it is clear that T2/T1 = E0/S0 1. We conclude that T1 represents
a long timescale, associated with substrate depletion, while T2 represents a short timescale, associated
with the initial rapid uptake of enzyme.
Rescaling on the longer timescale, so that t = T1τ = τ/(k1E0), Eqs. (2.7)-(2.9) transform to give
ds
dτ
=−s(1− c)+κec, (3.3)
ε
dc
dτ
= s(1− c)−κmc, (3.4)
s(τ = 0) = 1, c(τ = 0) = 0, (3.5)
where ε =
E0
S0
, κe =
k−1
k1S0
and κm =
k−1+ k2
k1S0
. (3.6)
Comparing Eqs. (2.7)-(2.9) and (3.3)-(3.6) we note that nondimensionalization has reduced the number
of model parameters from five to three. We remark further that in Eq. (3.4), the initial conditions supply
dc(0)/dτ = 1/ε . Thus, if ε  1 then c will initially increase very rapidly on the timescale τ .
Case Study III: The Schmitz Model (Nondimensionalization)
The procedure for nondimensionalizing the Schmitz model is identical to that used for the enzyme ki-
netics model. As the dimension of the system increases, and more processes are included, the number
of ways to rescale the independent and dependent variables increases rapidly. In such situations, it is
important to consider which variables are expected to vary and over what timescale: the answers to these
questions should help to identify appropriate scalings.
When studying Wnt signaling, inactivation of the DC plays a key role in the system dynamics and
therefore when we nondimensionalize the Schmitz model time is rescaled so that t = τ/δ15 (δ−115 is
the timescale for inactivation of the DC). Variables relating to free β -catenin (i.e X ,Xn,Xp,Xpn) are all
rescaled with B˜= δ0/δ15, the amount of β -catenin produced during the typical timescale t˜. This scaling
eliminates δ0 from the dimensionless equations (see below). When choosing the scalings for variables
involving DC and TCF, we aim to preserve conservation laws. Accordingly, guided by Eqs. (2.36), we
scale Ya,Yi,Yan,CXY and CXYn with YTOT , the total amount of DC in the system. Similarly, we scale T
and CXT with TTOT , the total amount of TCF in the system. Summarizing, we have
(X ,Xn,Xp,Xpn) = B˜(x,xn,xp,xpn), (Ya,Yi,Yan,CXY ,CXYn) = YTOT (ya,yi,yan,cxy,cxyn),
(T,CXT ) = T0 (θ ,cxθ ),
where x(τ),xn(τ), . . . ,cxθ (τ) are dimensionless variables. Under these scalings, the Schmitz model gives
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the following nondimensional system:
x′ = 1+(δ˜2xn− δ˜1x)+(δ˜6cxy− δ˜5xya), (3.7)
x′n = (δ˜1x− δ˜2xn)+(δ˜9cxyn− δ˜8xnyan)+(δ˜12cxθ − δ˜11xnθ), (3.8)
x′p = δ˜7cxy− δ˜13xp, (3.9)
x′pn = δ˜10Cxyn− δ˜14xpn, (3.10)
1
ω
y′a =
1
ω
(δ˜4yan− δ˜3ya)+(δ˜6cxy− δ˜5xya)+ δ˜7cxy+ 1ω (δ˜16yi− ya), (3.11)
1
ω
y′i =
1
ω
(ya− δ˜16yi, (3.12)
1
ω
y′an =
1
ω
(δ˜3ya− δ˜4yan)+(δ˜9cxyn− δ˜8xnyan)+ δ˜10cxyn, (3.13)
1
ω
c′xy = (δ˜5xya− δ˜6cxy)+ δ˜7cxy, (3.14)
1
ω
c′xyn = (δ˜8xnyan− δ˜9cxyn)− δ˜10cxyn, (3.15)
1
ν
θ ′ = (δ˜12cXT − δ˜11xnθ), (3.16)
1
ν
c′xθ = (δ˜11xnθ − δ˜12cxθ ), (3.17)
where primes denote differentiation with respect to τ and δ˜i (i= 1, . . . ,16) are the following dimension-
less parameters:
δ˜1 =
δ1
δ15
, δ˜2 =
δ2
δ15
, δ˜3 =
δ3
δ15
, δ˜4 =
δ4
δ15
, δ˜5 =
δ5YTOT
δ15
, (3.18)
δ˜6 =
δ6YTOT
δ0
, δ˜7 =
δ7YTOT
δ0
, δ˜8 =
δ8YTOT
δ15
, δ˜9 =
δ9YTOT
δ0
, δ˜10 =
δ10YTOT
δ0
, (3.19)
δ˜11 =
δ11T0
δ15
, δ˜12 =
δ12T0
δ0
, δ˜13 =
δ13
δ15
, δ˜14 =
δ14
δ15
, δ˜16 =
δ16
δ15
, (3.20)
ω =
(δ0/δ15)
YTOT
and ν =
(δ0/δ15)
T0
. (3.21)
3.3 Asymptotic Analysis
In applied mathematics, if the (dimensionless) governing equations contain a small parameter, it is com-
mon to assume that there is an asymptotic expansion for the solution, as a power series in the small
parameter. As we demonstrate below, this technique can be used systematically to simplify a mathemat-
ical model and, in so doing, provide useful information about the dynamics of its components.
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Case Study I: The Enzyme Kinetics Model (Asymptotics)
A key assumption of the enzyme kinetics model is that initial enzyme levels are much smaller than
substrate levels. This assumption is represented in the dimensionless model equations via the small
parameter ε = E0/S0 1. We exploit this small parameter by seeking a solution to Eqs. (3.3)-(3.5) of
the form
s(τ)∼ s0(τ)+ εs1(τ), c(τ)∼ c0(τ)+ εc1(τ). (3.22)
Substituting with Eq. (3.22) in the governing equations and equating to zero terms of O(εn), we deduce
that, at leading order, s0 and c0 satisfy
ds0
dτ
= κec0− s0(1− c0), (3.23)
0 = s0(1− c0)−κmc0, (3.24)
s0(0) = 1, c0(0) = 0. (3.25)
Thus the ODE for c reduces to an algebraic relation, giving c0 in terms of s0, and an ODE for s0, with
the implicit solution
κm logs0(τ)+ s0(τ) = A−κτ, c0 = s0κm+ s0 , (3.26)
where A is a constant of integration. A problem arises when we attempt to impose the initial conditions:
it is not possible simultaneously to satisfy both initial conditions. This is because the leading order
problem is of lower order than the original one.
In order to resolve this problem, we use matched asymptotic expansions. We recall that c varies
rapidly near τ = 0 and, hence, examine the system dynamics near τ = 0 by switching to the short
timescale T = τ/ε . In terms of T , the model becomes
ds˜
dT
= ε(κec˜− s˜(1− c˜), (3.27)
dc˜
dT
= s˜(1− c˜)−κmc˜, (3.28)
s˜(0) = 1, c˜(0) = 0. (3.29)
where s˜(T ) = s(τ), c˜(T ) = c(τ). As before, we seek asymptotic expansions for s˜ and c˜ in terms of ε 1,
of the form specified at Eq. (3.22). In this way, we obtain the following leading order solutions for s˜0(T )
and c˜0(T ):
s˜0(T ) = 1, c˜0(T ) =
1− e−(1+κm)T
1+κm
. (3.30)
The above approximate solution is accurate near τ = 0 but not for τ = O(1), whereas Eq. (3.26) is
accurate for τ = O(1) but not for τ  1 . The method of matched asymptotics involves choosing the
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constant of integration A to match Eqs. (3.26) and (3.30) [39]. By imposing the matching conditions
lim
τ→0
(s0(τ),c0(τ)) = lim
T→∞
(s˜0(T ), c˜c(T )),
we deduce that A= 1.
In practice, similar asymptotic analyses can be used to study ODE models of signaling pathways.
As we have seen, such models may involve large numbers of variables and parameters, and estimates
for many parameters may be lacking. In such cases, progress can be made by using order of magnitude
estimates for certain processes. For example, in [29], the authors assume that all binding reactions are
rapid, apart from the binding of GSK3β to APC/Axin. Under this fast kinetics assumption, the ODEs for
the relevant species reduce to algebraic equations, in the same way that, for the enzyme kinetics model,
on the longer timescale the ODE for the complex c reduces to an algebraic relation (see Eq. (3.24)).
To the best of our knowledge, the Schmitz model has yet to be subject to such asymptotic analysis.
Referring to Eqs. (3.7)-(3.17), and by analogy with the asymptotic analysis of the enzyme kinetics model
presented above, we note that the dynamics of the system will be strongly influenced by the ratios ω and
ν . For example, if typical levels of β -catenin are much greater than levels of TCF and DC then we
could construct approximate solutions to the Schmitz model in the limit for which ν  1 ω . Such an
analysis of the Lee model was performed by [40]. Since the details are rather involved, we summarize
the key points below, and refer the interested reader to [40] for further details.
Case Study II: The Lee Model (Asymptotics)
Numerical simulations of the Lee model generated using parameter estimates reported in [29] (see Fig-
ure 5) suggest that the processes involved in the Wnt signaling pathway act over at least two different
timescales. Lee et al.’s parameter estimates indicate that the basal rate at which β -catenin is degraded is
much smaller than the rate at which the DC becomes inactive. This discrepancy is exploited to define a
small parameter, η = α16/α15, which is the ratio of the rate at which β -catenin undergoes natural decay
to the rate at which the DC becomes inactive. The dimensionless parameters are then rescaled by multi-
plying them by appropriate powers of η so that they are O(1). By retaining terms of leading order, the
20
Figure 4. Series of schematics showing which components of the Lee model of Wnt signaling are
active on the short (top), medium (middle) and long timescales. The active components on each
timescale are highlighted with bold borders. Figure reproduced from [40], with permission.
21
!"?# !"?$ !"?% !"?! !"" !"! !"% !"$
"
"&%
"&#
"&'
"&(
!
)*+,-./0,12*2?3./4
5
*2
6&
,12
*2
?3
./
4
7,18.9:0;0))034
!"?# !"?$ !"?% !"?! !"" !"! !"% !"$
"
!
%
$
)*+,-./0,12*2?3./4
5
*2
6&
,12
*2
?3
./
4
<,1=>.24
!"?# !"?$ !"?% !"?! !"" !"! !"% !"$
"
%
#
'
(
)*+,-./0,12*2?3./4
5
*2
6&
,12
*2
?3
./
4
8
.
,1=?5@=>.2@ABC$?4
!"?# !"?$ !"?% !"?! !"" !"! !"% !"$
"
&
!"
!&
%"
'()*+,-.*/0(0?1,-2
3
(0
45
*/0
(0
?1
,-
2
6
7
*/893:;8<,0:;=>?$?2
!"?# !"?$ !"?% !"?! !"" !"! !"% !"$
"
!
%
$
#
'()*+,-.*/0(0?1,-2
3
(0
45
*/0
(0
?1
,-
2
6
@
*/??47A.0,0:;893:;8<,0:;=>?$?2
!"?# !"?$ !"?% !"?! !"" !"! !"% !"$
"
%
#
B
'()*+,-.*/0(0?1,-2
3
(0
45
*/0
(0
?1
,-
2
C
7
*/??47A.0,02
Figure 5. Series of figures showing how the Lee model responds to a Wnt stimulus (W = 1) that is
applied at t = 0 when the pathway is in equilibrium (W = 0) at t = 0. Also shown is the asymptotic
solution obtained by matching the short, medium and long time approximations to the Lee model.
There is good agreement between the approximate and numerical solutions at all timescales. Key:
numerical simulations of the (dimensionless) Lee model, Eqs. (2.10)-(2.24) (solid line); Short, medium
and long time approximations are represented by dash-dotted, dotted and dashed lines respectively.
Figure reproduced from [40], with permission.
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following reduced model is obtained:
dDa
dt
= α¯1W (1−Da)− α¯2Da, (3.31)
dYi
dt
=−(α¯5Da+ α¯3+ α¯7)Yi+Ya+ α¯6N1+ηK¯1X , (3.32)
η
dCXY
dt
= α¯10XYa− α¯11CXY , (3.33)
dN
dt
=
(
(α¯5Da+ α¯7)Yi−
(
α¯6
(1+ηK¯1X)
+ α¯18
)
N+1
)
1
1+ K¯2
, (3.34)
dYa
dt
=
α¯3Yi−Ya− dCXYdt
1+ K¯3X
, (3.35)
1
η
dX
dt
= α¯15− α¯10XYa− α¯16X . (3.36)
We remark that Eq. (3.31) decouples and if a constant Wnt stimulus is applied (W (t) =W , constant)
then
Da→ α¯1Wα¯1+ α¯2 .
We note further that the time derivatives in Eqs. (3.31)-(3.36) are premultiplied by three different powers
of η . This suggests that model processes act on three distinct timescales, a prediction that is consistent
with the rapid fluctuations and slow increases depicted in Figure 5.
As for the enzyme kinetics model (Eq. 3.22), it is possible to analyze the reduced Lee model on the
short, medium and long timescales for which t = O(η),O(1) and O(η−1) respectively. In each case,
asymptotic expansions in powers of the small parameter η are sought and used to simplify the governing
equations. The results of this analysis can be summarized as follows (see [40] for details).
1. Short timescale (t = O(η)): all model variables except Yi and CXY are constant, at leading order.
The dominant reaction is phosphorylation of β -catenin by active destruction complex.
2. Intermediate timescale (t = O(1)): the dominant reaction is found to involve inactivation of the
destruction complex.
3. Long timescale (t = O(η−1)): the dynamics are dominated by degradation of free β -catenin.
Pathway components acting on the short, intermediate and long timescales are highlighted in Figure 4
while Figure 5 shows good agreement between the approximate solutions and those of the full model.
3.4 Parameter Analyses
The selection of model parameters, their physical meaning and numerical value are especially impor-
tant; therefore, parameter analysis examines the response of the system to changes in parameters. Many
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methods for estimating parameters depend on time course data. These data generally give a quantitative
measure of the variable level, such as mRNA or protein concentration level, at different time points.
Testing a model against experimental data is a good way to validate or invalidate it; however, gathering
experimental data is often too expensive to determine all parameter values and overfitting, i.e., describing
noise instead of the relationship, is a risk, as demonstrated for Wnt signaling later in this section. Fol-
lowing parameter estimation (using optimization) or parameter inference (using statistics), a good way
to test a model is by performing parameter sensitivity analysis: this evaluates qualitative or quantitative
relationships between parameters and their effect on the system outcome [41].
Parameter Estimation and Wnt Data
Ultimately, every model should be tested against data, a process that can either invalidate the model or
provide evidence in its favor, if it provides a good fit under acceptable conditions. The aim is to esti-
mate parameters that drive the model close to the data; this can be done using minimization techniques.
Effectively, one calculates an objective function which is defined as the difference between the model
simulated for particular value of parameters κ and the observations (data), and aims to minimize the error
of the objective function, often performed iteratively [42–44].
Since publication of the Lee model [29], where estimates of the parameters controlling Wnt signaling
were based on data from Xenopus extracts, few studies have quantitatively studied the dynamics of the
Wnt pathway. This knowledge gap means that currently it remains difficult to test the models that have
arisen in recent years. This problem is not uncommon in systems medicine. We also remark that the
Xenopus data gathered by Lee et al. may be markedly different from those for mammalian Wnt signaling.
In [13], dynamic changes in β -catenin levels were investigated in Xenopus extracts. They demonstrated
that absolute levels of β -catenin did not dictate the Wnt signaling outcome: rather the β -catenin fold-
change was the crucial variable. They used the Lee model to test their experimental results and, via
sensitivity analysis, identified that the model confirmed their experimental findings.
Quantification of Wnt signaling in mammalian cell lines was undertaken by [14, 15]. Discrepancies
with data from Xenopus extracts (such as higher Axin levels and lower APC levels in mammalian cells)
highlight the need for caution in data gathering and for further quantification of the pathway. Since these
measurements were made at steady state, they do not yet permit elucidation of transient Wnt signaling.
More recent measurements of cytoplasmic and nuclear β -catenin in response to a Wnt stimulus provide
a valuable first look at the dynamics of the pathway [45].
The above studies provide preliminary insight into the Wnt pathway but much remains to be done.
The data are not yet of sufficient quality to discriminate between most models (which typically contain
many molecular species). Caution must be taken when applying data. For example, where data generated
from non-mammalian systems may be used in a model that addresses clinical outcomes. For systems
medicine to have the greatest impact, modeling (with prediction) and experimentation (to test predictions)
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must proceed iteratively.
Parameter Inference
There are often cases where it is either infeasible or impossible experimentally to determine values
for parameters that describe a given model. In such cases, we may be able to estimate (some of) the
parameters using statistical inference. In general the aim is to identify the values of the parameters, θ ,
(ideally including corresponding confidence regions) for which a model best explains the data.
A reliable way of doing so is to focus on the likelihood L(θ), which is defined as the probability of
observing the data (x) given parameters (θ ):
L(θ) := P(x|θ).
Varying θ to identify the value for which this probability is maximized gives the maximum-likelihood
estimate. There is a rich literature on this topic and how confidence of the estimates can be assessed [46].
Likelihood estimates center around the available data. In many circumstances we may have addi-
tional information, for example based on biophysical arguments, about which parameter values can be
ruled out. Incorporating such prior information is hard in a pure likelihood framework, but lies at the
heart of Bayesian inference [47]. Here inferences are based on the posterior distribution over model
parameters. The posterior distribution can be described starting from Bayes rule:
P(θ |x) ∝ P(x|θ)pi(θ). (3.37)
P(θ |x), the probability of θ given x, is called the posterior probability, P(x|θ) is the likelihood function,
and pi(θ) is the prior probability (knowledge about parameters before we begin fitting to data) [48]. As
well as the full (joint) posterior distribution, one may also analyze the marginal posterior distributions
which are the individual distributions over each parameter.
In certain cases, such as for large, complex systems, computing the likelihood is impractical. In such
cases approximate Bayesian computation (ABC) should be considered [49]. Instead of the likelihood, a
distance function is used to compare the actual data with data simulated by a model, denoted xm. If the
underlying model is given by f = f (xm|θ), then we express the ABC posterior function by
PABC(θ |x) ∝ 1(∆(x,xm)≤ ε) f (xm|θ)pi(θ) (3.38)
where ∆(a,b) denotes a distance measure between a and b and ε is the tolerance level that determines
how well real and simulated data should agree.
By evaluating the posterior function, ABC allows the modeler to identify parameter regions that are
of interest, and ignore those that are not. Furthermore, the posterior distribution gives information about
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Figure 6. Data published in [45] were used to fit the Lee and Schmitz models using approximate
Bayesian computation for parameter inference. β -catenin concentration units were normalized based on
their initial values. From the inference, we can see that the Lee model provides a better fit to the data.
joint distributions in parameter space and can reveal multivariate dependencies between parameters.
ABC for parameter inference has been implemented in the software package ABC-SysBio with sup-
port for parallelization [50]. For the examples given below, we used the CUDA implementation of
ABC-SysBio with a Euclidean distance measure between model and data [51,52]. Proceeding to analyze
the Lee and Schmitz models, we do not try to infer all of the model parameters, since this is not possible
with the data available, but instead study a 3D subset of parameter space. We choose free parameters that
have direct (or strong) influence on the dynamics of β -catenin, since this is the species for which we have
experimental measurements. The data used for fitting are published in [45]: they describe how the level
of β -catenin changes over time in the cytoplasm and nucleus, following application of a Wnt stimulus to
the system. These data, alongside the results of the parameter inference, are shown in Figure 6.
For the Lee model, we study the β -catenin-DC binding rate (α10), that has a prior of [0,100], the
β -catenin degradation rate that is independent of the DC (α16), and the binding rate of β -catenin to
TCF (α19). The latter two parameters both have priors of [0,1]. The marginal posterior distributions for
these three parameters (Figure 7) show that the β -catenin-DC binding parameter takes values over the
lower half of its prior range, whereas the other two parameters can take any values spanning the prior
range. This suggests that for this model the parameter that has the greatest impact on outcome is the
β -catenin-DC binding rate, however we note the larger prior range over this parameter.
For the Schmitz model, we study the β -catenin production rate (δ0), the β -catenin shuttling rate (δ1),
and the binding rate of β -catenin to TCF (δ11). The prior used for each parameter is [0,1] and we see
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Figure 7. Posterior distributions and sensitivity analysis for the Lee and Schmitz models. Histograms of
marginal posteriors for each free parameter in the two models are shown. The marginal posterior is the
probability distribution for a single parameter, given data describing β -catenin dynamics in cytoplasmic
and nuclear compartments [45]. Principal component (PC) analysis allows us to assess the sensitivity of
the parameters to small perturbations: the last PC, PC3, contains the most sensitive parameters. We see
that for each model, two parameters dominate PC3 and, thus, are most sensitive in this system.
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from Figure 7 that the marginal posterior distributions are relatively stiff: each parameter is constrained
to lie within a narrow range relative to its prior. In order to fit the data, the rates of β -catenin shuttling
and binding to TCF must be low, whilst the rate of β -catenin production must be high.
Sensitivity Analysis
Sensitivity analysis investigates how a model responds to perturbations around a set of parameter values
and characterizes its robustness: a robust system is one for which perturbations of the parameters or initial
conditions do not change the outcome. However, many trade-offs between sensitivity and robustness
exist [53–55].
Local sensitivity analysis determines how parameter perturbations affect the output of a system.
Estimated or inferred parameters can be used as a baseline for parameter sensitivity. If the output of
dx/dt = f (x,κ) is approximated by a first-order Taylor series in a neighborhood of reference input
values, then the local sensitivity coefficient, si, j is the partial derivative of the ith state to the jth parameter:
si, j(t) =
∂xi(t)
∂κ j
, (3.39)
The elements si, j define a sensitivity matrix S = ∂x/∂κ . This local method provides information about
the sensitivity in a given parameter region but not the global sensitivity landscape. Local sensitivity
analysis can reveal parameters that are sensitive or robust to perturbations in the region of interest.
Principal component analysis (PCA) offers another way to investigate system sensitivity. This tech-
nique can be readily applied to the posterior distribution obtained following Bayesian inference. The
principal components are constructed by evaluating the eigenvalues and eigenvectors of the covariance
matrix of the parameters: the first principal component (given by the largest eigenvalue) corresponds to
the direction in which the posterior is most wide; the last principal component (given by the smallest
eigenvalue) corresponds to the direction in which the posterior is most narrow [49, 56]. The last few
principal components represent the most sensitive (or “stiff” parameters) [57].
In Figure 7, sensitivity analysis via PCA for the Lee and Schmitz models is shown. The principal
components (PC) are ordered 1 – 3 thus PC3 is the last component and contains the most sensitive
parameter combinations. For both models, PC3 is dominated by two parameters: the rates of β -catenin
binding to the destruction complex (DC) or to TCF for the Lee model (α10,α19); and the rates of β -
catenin production or binding to TCF for the Schmitz model (δ0,δ11). These results suggest that the Lee
model is more robust to changes in the β -catenin degradation rate (α16), and that the Schmitz model is
more robust to changes in the β -catenin shuttling rate (δ1).
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4 Techniques for the Comparison and Discrimination of Models
Given a set of models that describe similar biological phenomena, a challenge is to determine which
model best describes the system, given the evidence available. In this section we describe two methods
that enable comparison and discrimination between models. The first employs approximate Bayesian
computation, introduced above, and has already gained a strong foothold in systems medicine [50, 58–
60]. The second is model discrimination with the use of algebraic matroids; as far as we know this is a
recent addition to the modeler’s toolkit and holds great potential for advances in systems medicine.
4.1 Model Selection via Approximate Bayesian Computation
Returning now to the Lee and Schmitz models, we consider how to choose between models using ABC
model selection. We have already demonstrated how methods for parameter inference, such as ABC, can
yield the posterior distributions over the parameters of a model (given data) and discussed briefly how
this can be interpreted. For two or more models (Mi, i= 1, . . . ,n) some measure of the evidence for each
model is needed [61],
P(Mi|x) ∝ P(x|Mi)pi(Mi), (4.1)
where (as previously) x represents the data, and pi the prior probability.
The ABC approach may be extended to parameter inference and model selection simultaneously
using a joint space approach [49]. This may be performed for M models where M = [M1, . . . ,Mn],
by assigning to each model (and parameters therein) a prior distribution and perturbation kernel that
designates weights for model transition. The algorithm accepts N particles at the εF tolerance, which
forms the joint posterior distribution P(α,M|xˆ) and upon marginalizing over parameters, the marginal
posterior distribution P(M|xˆ) is approximated, providing a measurement for model selection. Bayesian
model selection, like other approaches including the likelihood ratio test or Akaike Information Criteria
(AIC), also penalizes over-parameterization.
The AIC for model Mi, with i ∈ {1, . . . ,n}, is defined as
AICi =−2logL(θ ∗i ;x,Mi)+2ki, (4.2)
where L is the likelihood, and θ ∗i and ki are (respectively) the maximum likelihood parameter and num-
ber of parameters in model Mi. This criterion, probably the best known model selection tool, makes
explicit the penalty for an increased number of parameters. However, as the amount of data increases,
the AIC introduces bias and tends to favor models that are over-parameterized. Therefore the Bayesian
information criterion (BIC),
BICi =−2logL(θ ∗i ;x,Mi)+ ki logn, (4.3)
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Figure 8. Model selection via ABC for the Lee and Schmitz models. The results show that, over
successive populations, evidence in favor of the Lee model grows until there is a high probability that
this model will be selected, given the data published in [45].
may be preferred, as it remains unbiased for large samples, n. The BIC is effectively an approximation
to the model probability (4.1); the penalty term, explicit in the AIC and BIC definitions, is implicit in
(4.1), where it enters via the parameter priors for each model.
Model selection chooses, from among a set of candidate models, the model that best explains ob-
served data. Two things need to be kept in mind: (i) one model will always be chosen as the best but this
does not mean that the model is necessarily a good one; ideally model selection should go hand-in-hand
with model checking (and topological sensitivity analysis [62]). (ii) model selection depends on the data
available for testing the different models; since different data may favor different models, careful exper-
imental design should precede model selection. With these issues in mind we have the pragmatic choice
about which statistical model selection framework to employ. Fully Bayesian, even in an ABC context,
is more expensive than identifying the maximum likelihood parameter set and applying AIC or BIC.
Shown in Figure 8 are the results of ABC model selection for the Lee and Schmitz models, with the
probability of the model given for successive iterations (populations). We see that initially both models
are equally probable, but subsequently the probability of selecting the Schmitz model drops to close to
zero and we conclude that the Lee model is favorable given these data and parameter combinations.
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4.2 Model Discrimination using Parameter-Free (Algebraic) Approaches
When parameter values are unknown or cannot be estimated from data, one may still be able to discrimi-
nate between competing models. We present two approaches, one that requires no data (rather qualitative
insight into whether the system can have multiple responses) and another method which requires either
highly resolved single cell data or multiple replicates of steady-state measurements.
Precluding/Asserting Behaviors via Chemical Reaction Network Theory
Chemical reaction network theory (CRNT) studies the structure of a model (which can also be described
as a network) constructed from chemical reactions without relying on specific parameter values. The
aim here is to use such theory to preclude (and sometimes assert) possible qualitative behaviors in the
positive orthant, i.e., R>0. Cases where multiple positive states are stable (i.e., biologically accessible)
are of particular biological importance for cellular decision making, for example, differentiation into one
of two or more specialized cell lineages.
The field of CRNT initially focused on a structural property of a model called deficiency, which could
preclude multiple steady-states [63, 64]. Then theorems were proved for precluding/asserting multiple
equilibria by studying the cycles in the graph of a network, or the sign of the determinant of the Jacobian;
some of these approaches can provide conditions on the parameters for behaviors such as bistability and
oscillations [65–70]. An excellent and comprehensive survey of techniques for multistationarity was
written by Joshi and Shiu [71]. One main tool for precluding multistationarity of a model is testing
whether it is injective (a model, including conservation relations, is injective if F(x,κ) = F(x˜,κ)⇒
x = x˜). Here we demonstrate the application of multistationarity tests (developed for chemical reaction
networks) to Wnt signaling models.
We begin with the Lee model. First we test injectivity, noting that while injectivity precludes mul-
tistationarity, failure of injectivity does not imply multistationarity. We use the algorithms in the CRNT
Toolbox to determine whether the system can ever admit multiple positive steady states–multistationarity
[72]. The Lee model fails injectivity, but cannot admit multiple positive steady states for any values of the
system parameters and/or total concentration amounts (algorithms within [72]). Conversely, the Schmitz
model has the capacity for multiple steady-states; however, as calculated earlier, only one can ever be
stable. Therefore, in this example, since both models only can have one stable steady-state, it is difficult
to use only qualitative data to discriminate between them. Clearly, if data suggested two stable states
could exist (for example via flow cytometry), and all of the data had the same initial conditions, then one
could rule both models out.
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Model Discrimination using Coplanarity via Algebraic Geometry
When data from a model clearly supports a specific behavior — whether monostable, bistable, or os-
cillatory, qualitative approaches such as those mentioned above may be a good first step for classifying
models, especially if the data are not sufficient to estimate parameters. However if steady state data are
available, then determining steady-state invariants may be helpful for determining whether a model is
compatible with given data using a statistical parameter-free model discrimination method.
Since often data are not available for all model species, variables must be eliminated. A system-
atic technique from algebraic geometry proceeds by computing the Gröbner Bases of the model variety
(studying the model at steady-state) and eliminating unobservable variables. The resulting steady-state
invariant enables us to focus on part of the system and to test whether the data suggests that the rela-
tionships between species still hold. Notions of dependence and independence between model variables
can also be studied using algebraic matroids and were recently applied to steady-state model discrimina-
tion [27].
For smaller models, the steady states can be determined explicitly. For example, for the Schmitz
model, the steady state values can be expressed in terms of X and Xn: all other variables can be eliminated
by exploiting conservation laws and using variable substitution (see Eqs. (3.1)-(3.2)). Either by hand,
by computing the matroid, or by using Gröbner bases, the polynomial relationship/algebraic dependence
between X and Xn in the Schmitz model gives the following invariant:
I = δ0δ3δ4δ6(δ8+δ9)X2+(δ0δ2δ7δ9(δ5+δ6)−δ1δ3δ4δ6(δ8+δ9))XXn−δ1δ2δ7δ9(δ5+δ6)X2n ,
which vanishes at steady-state (i.e., I = 0). Effectively, we aim to test whether the data are coplanar
with our model, via the steady-state invariant transformation. Model compatibility is determined by
computing the coplanarity error (∆) via the singular value decomposition of the matrix Xˆ2 Xˆ2n Xˆ Xˆn

 h˜1h˜2
h˜3
= 0,
where Xˆ denotes the observed value of species X . The null hypothesis (that the model is compatible with
the data) can be rejected when the coplanarity error (normalized smallest singular value) is less than a
statistical bound, which is determined by the Gaussian measurement noise in the data and the invariant
structure [73]. This method was recently applied to β -catenin localization data (cytoplasmic, X ; and
nuclear, Xn) published in [27,45]. The Schmitz model could be ruled out if data were perturbed less than
10−5 by measurement error/noise; for higher levels of noise, the model is compatible.
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5 Discussion
Paradoxically, technological advances can sometimes create new challenges for clinicians. For example,
as the number and variety of treatments for cancer increase, it can be difficult to identify the combination
of treatments that will most benefit a given patient (if a unique, optimal treatment even exists). The
situation is further complicated when we consider the different types of data that can be used as a basis
for diagnosis and treatment planning; it is often impossible to integrate the available data by linear
thinking alone. Systems medicine aims to address these challenges by developing mathematical and
computational tools that integrate different types of information in order to generate objective decisions
for patient treatment. In this chapter we have focused on ODE models, a class of models widely used in
systems medicine, particularly to study signaling pathways. We have reviewed a variety of techniques
that can be used to develop and analyze ODE models, using models of enzyme kinetics and the Wnt
signaling pathway as test cases.
Many of the techniques that we have presented are already well-established (such as model develop-
ment, nondimensionalization, identification of steady state solutions, asymptotic analysis, and parameter
sensitivity analysis); however others are less well-known (such as approximate Bayesian computation,
chemical reaction network theory, and matroid-informed coplanarity). In addition to the benefit that these
methods bring to the field, model development for systems medicine – in its increasing sophistication –
is helping to stimulate further development and application of mathematical and statistical techniques.
Many of the challenges in systems medicine arise because most biological processes, including path-
ways, do not act in isolation. For example, at the subcellular level, pathway cross-talk can have a sig-
nificant effect on cell function. In particular, there is growing evidence of cross-talk between Wnt and
E-cadherin [74], Wnt and Erk [33]) and Wnt and the Hippo pathway [75]. Even simplistic models of
such pathway cross-talk quickly become large and demand sophisticated techniques for their analysis.
The situation becomes more complex when we consider the impact of signaling pathways at the mul-
ticellular and tissue scales. The impact of Wnt signaling at the multicellular and tissue levels has been
studied theoretically, most prominently in models of intestinal crypts [76–79]. These models (for ex-
ample) introduce spatial dependence by imposing a graded Wnt distribution along the crypt axis [78]
or provide comparison of a continuum model with a cell-based model that incorporates heterogeneity
and noise [79]. In [74], a multiscale model of interactions between the pathways affecting β -catenin
and E-cadherin is developed and used to study the role of epithelial-mesenchymal transitions in can-
cer growth and metastasis, whereas in [80] a simple rule-based model for cross-talk between the Wnt
and delta-notch pathways is embedded within discrete epithelial cell agents and used to study cell fate
specification within the intestinal crypt. In addition to these theoretical studies (ever growing in com-
plexity), more sophisticated data collection is urgently needed as a basis for hypothesis testing and model
(in)validation.
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We end by proposing two grand challenges, whose solutions will bear much fruit in systems medicine.
The first is to incorporate multiple levels of information — from biochemical reactions within a single
cell, to tissue-level processes — into cohesive models. The second is to incorporate data which is re-
solved in space and time into a theoretical framework. There are, of course, many other examples, and
work in these areas should provide many exciting opportunities for theoreticians in systems medicine for
years to come.
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